|
|
| |
| Most Discussed Stocks |
 |
|
|
|
| |
|
News |
| |
|
WILL THE FDA GIVE THE GREEN LIGHT T.... |
10/06/2008 |
|
Has the time come for Provenge, the prostate cancer vaccine developed by Dendreon, to be given marketing approval so it can save condemned metastatic prostate cancer patients’ lives? |
| |
|
PROGENICS: THE HIV DRUG LOOKS PROMI.... |
10/02/2008 |
|
|
| |
|
WE WILL BE ALL RIGHT |
09/25/2008 |
|
We gave you Sequenom and many other winners. Prohost will continue to do the same, hopefully without as much struggling against the greed of those who took advantage of the market deregulation to turn it into a vehicle for self-fulfillment of destructive prophesies at the expense of the serious investors.
We surely believe that America is capable of overcoming this crisis. Yet, our hope is in a reform that stops the greed that tarnished the market’s and America’s strong economy’s reputation.
We will be all right.
|
| |
|
SEQUENOM (SQNM): SUCCESS OF NON INV.... |
09/24/2008 |
|
The results are 100% without manipulation of the fetus and with a simple mother\'s blood test. |
| |
|
CYTRX COMPLETES ITS BUYOUT OF INNOV.... |
09/23/2008 |
|
Cytrx inherited the cancer drug tamibarotene, which has been approved in Japan for acute promyelocytic leukemia (APL). It also inherited three other drug candidates. Read about tamibarotene. Read also about the a stool test that shows successful results in diagnosing colorectal cancer. |
| |
|
|
| |
| |
| |
|
|
Stocks >> Stocks Details |
|
ACOR
|
| |
|
SPINAL CORD INJURY AND DISORDERS |
|
|
|
ACORDA THERAPEUTICS
|
| |
ACORDA THERAPEUTICS
(ACOR) develops drugs to restore neurological function in patients with spinal cord injury and other central nervous system disorders. Its lead drug
candidate, Fampridine-SR, enhances conduction in the myelin layer of nerves damaged
by blunt trauma or from multiple sclerosis (MS). The drug is delivered by a
sustained release system developed for the firm by Elan Corporation (ELN). Pipeline: Valrocemide for
epilepsy and other drugs for MS. The company has also acquired from Elan the
rights to market and sell muscle relaxant Zanaflex in the US. www.acorda.com
|
| |
| |
| |
| |
| |
| |
|
|
|
|
